Electromed Inc (ELMD) 2.48 $ELMD Edwards Lifesciences Up

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Electromed Inc (ELMD) 2.48 $ELMD

Edwards Lifesciences Up on Positive PARTNER Trial Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 18, 2:20PM CDT
The PARTNER trial data demonstrated durable valve performance in high-risk surgical heart patients who were treated with Edwards' (EW) first-generation transcatheter aortic valve - Sapien.
ABMD: 60.00 (-1.10), INGN: 32.05 (-0.10), EW: 146.77 (-2.17), ELMD: 2.48 (+0.07)

Philips' Volcano Receives CE Mark, Forays into New Markets - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 13, 2:30PM CDT
Leading healthcare, consumer lifestyle and lighting company, Royal Philips (PHG) has confirmed that its business unit Volcano has received the CE mark for the iFR Scout pullback software.
WHR: 197.95 (+3.81), PHG: 28.90 (-0.07), UEIC: 56.53 (+0.65), ELMD: 2.48 (+0.07)

Electromed ups revenues 40% in FQ2
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 9:50AM CST

ELMD: 2.48 (+0.07)

After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 4:39PM CST

BXE: 2.38 (+0.03), NOG: 7.05 (+0.02), IPHI: 19.07 (+0.32), PIR: 14.06 (+0.65), KEG: 1.83 (+0.16), CNQ: 29.60 (+0.86), SSNI: 9.75 (-0.02), GNW: 7.38 (+0.12), CHS: 18.24 (+0.11), ELMD: 2.48 (+0.07)

Electromed beats by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 3:56PM CST

ELMD: 2.48 (+0.07)

Electromed, Inc. Reports Higher Second Quarter Revenues and Profits
Business Wire - Tue Feb 10, 3:30PM CST
Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-and six-month periods ended December 31, 2014. Net revenues for the second quarter of fiscal 2015 rose approximately 40% to $4.9 million, compared to $3.5 million in the same quarter of fiscal 2014. The Company reported net income of $423,000, or $0.05 cents per basic and diluted share, for the second quarter of fiscal 2015, compared to a net loss of $239,000, or ($0.03) per basic and diluted share, for the same period of fiscal 2014.
ELMD: 2.48 (+0.07)

Volcano's Prospects Bright in Image-Guided Therapy Market - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 09, 5:00PM CST
Volcano (VOLC) reported adjusted loss per share of 4 cents in the quarter, narrower than the Zacks Consensus Estimate by 20%.
ABMD: 60.00 (-1.10), PHG: 28.90 (-0.07), VOLC: 17.99 (+0.01), ELMD: 2.48 (+0.07)

Thoratec (THOR) Downgraded to Strong Sell after Dismal Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 1:40PM CST
Thoratec Corp.'s (THOR) lackluster third-quarter 2014 results, with both earnings and revenues missing expectations, have set a negative earnings estimate revision trend for the company.
ABMD: 60.00 (-1.10), EW: 146.77 (-2.17), THOR: 40.14 (-0.40), ELMD: 2.48 (+0.07)

Bioanalytical Systems Q4 Loss Widens, Revenues Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 8:00AM CST
Bioanalytical Systems, Inc. (BASI) reported fourth quarter fiscal 2014 loss of 2 cents per share, which doubled from the year-ago loss of a penny
FLDM: 45.47 (-0.07), BASI: 1.98 (-0.06), INGN: 32.05 (-0.10), ELMD: 2.48 (+0.07)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 11:45AM CST

LTBR: 1.05 (-0.04), ASPS: 13.33 (+0.85), AETI: 3.36 (-0.18), PLUG: 2.66 (-0.05), MOC: 1.96 (-0.02), CRDS: 2.83 (+0.01), STKL: 11.01 (+0.50), BIOC: 2.45 (-0.12), CZR: 9.44 (unch), MATX: 41.66 (+0.06), NTIC: 19.87 (+1.29), SDPI: 3.01 (+0.01), RESN: 9.72 (-0.15), OREX: 7.19 (-0.41), FLL: 1.46 (unch), VGGL: 1.64 (+0.19), CGG: 6.02 (+0.20), SUSQ: 13.91 (+0.09), SINO: 1.50 (+0.02), ELMD: 2.48 (+0.07)

Electromed, Inc. Reports Higher First Quarter Revenues and Profits
Business Wire - Wed Nov 12, 8:01AM CST
Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for the three-month period ended September 30, 2014. Net revenues for the first quarter of fiscal 2015 rose approximately 40% to $4.8 million, compared to $3.4 million in the first quarter of fiscal 2014. The Company reported net income of $378,000, or $0.05 cents per basic and diluted share, for the first quarter of fiscal 2015, compared to a net loss of $335,000, or ($0.04) cents per basic and diluted share, for the same period of fiscal 2014.
ELMD: 2.48 (+0.07)

Masimo Beats Q3 Earnings Estimates, Cuts Revenue Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 12:49PM CDT
Masimo Corp (MASI) reported earnings of 27 cents per share in the third quarter of 2014, which beat the Zacks Consensus Estimate by a couple of cents
ATEC: 1.35 (-0.07), MASI: 31.01 (-0.55), CYNO: 30.79 (+0.33), ELMD: 2.48 (+0.07)

Electromed (ELMD) Upgraded From Sell to Hold
at The Street - Fri Sep 26, 8:05AM CDT
Electromed (ELMD) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-.
ELMD: 2.48 (+0.07)

Electromed jumps to net income of USD290,000 and revenues up 14.8% for Q4 fiscal 2014
M2 - Wed Sep 24, 7:39AM CDT
Airway clearance therapy company Electromed (NYSE MKT:ELMD) disclosed on Tuesday its net income of USD290,000 (USD0.04 per basic and diluted share) for its fourth quarter ended 30 June 2014.
ELMD: 2.48 (+0.07)

Electromed, Inc. Reports a Profit on Higher Fiscal 2014 Fourth Quarter Revenues
Business Wire - Tue Sep 23, 3:30PM CDT
Electromed, Inc. (NYSE MKT: ELMD) today announced financial results for its fourth quarter and fiscal year ended June 30, 2014.
ELMD: 2.48 (+0.07)

Electromed, Inc. Names Lee Jones to its Board of Directors
Business Wire - Tue Sep 02, 3:30PM CDT
Electromed, Inc. (NASDAQ: ELMD), announced today that its Board of Directors has elected Lee Jones to the Board. Ms. Jones has served as the President and Chief Executive Officer of Rebiotix Inc. since 2011 and as a director of Uroplasty, Inc. since 2006.
UPI: 1.10 (-0.03), ELMD: 2.48 (+0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 6

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 2

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 6

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
BusyBee AI Revolutionizes Classroom Feedback Efficiency

Updated Category News Views 7

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...

Continue Reading

Top 5 Most Recently Viewed Articles

First Industrial Realty Trust Excels in Q2 2025 Performance

Updated Category News Views 170

Strong Financial Results for First Industrial Realty Trust First Industrial Realty Trust, Inc. (NYSE: FR) announced notable financial results for its second quarter of 2025. This leading owner and operator of logistics real estate illustrated a remarkable cash same-store net operating income (NOI) growth of 8.7%, showcasing its strong market position and operational...

Continue Reading
Range Resources Announces New Quarterly Dividend

Updated Category News Views 84

Range Resources Announces New Quarterly Dividend Range Resources Corporation (NYSE: RRC) has shared some exciting news about its dividend distribution. The company's Board of Directors has officially declared a cash dividend of $0.08 per share, which is set to be distributed in the third quarter. This decision highlights Range's dedication to delivering value to its loyal...

Continue Reading
Highlights of Ringkjøbing Landbobank's Recent Buyback Program

Updated Category News Views 157

Completion of the Share Buyback Program The share buyback program initiated by Ringkjøbing Landbobank has successfully completed its target of DKK 500 million. This initiative demonstrated the bank’s commitment to enhancing shareholder value. The buybacks took place between January 28 and May 28. Details of the Transactions During the reporting period, several...

Continue Reading
Monte Rosa Therapeutics Updates on MRT-2359 Study Progress

Updated Category News Views 175

Monte Rosa Therapeutics Announces Progress in MRT-2359 Study Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a pioneering clinical-stage biotechnology company, has shared exciting updates regarding its ongoing Phase 1/2 study of MRT-2359. This innovative treatment targets MYC-driven solid tumors and has shown promising results in patient safety and drug efficacy. Key Study...

Continue Reading
Pentagon Budget Sparks AI Innovations in Defense Sector

Updated Category News Views 103

Defense Sector Transforms with AI Technologies The recent authorization of a significant $900.6 billion Pentagon budget marks the beginning of a dynamic transformation in the defense industry. This substantial financial allocation urges the need for innovation in electronic warfare and advanced sensing technologies as the complexity of modern threats increases. Experts...

Continue Reading